✦ LIBER ✦

In vitro model system to predict efficacy of estrogens to prevent versus treat Alzheimer’s disease

✍ Scribed by Roberta Diaz Brinton; Shuhua Chen

Book ID: 118461897
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 48 KB
Volume: 1
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2005.06.268

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Quantitative Pharmacology Approach in Al

Quantitative Pharmacology Approach in Alzheimer’s Disease: Efficacy Modeling of Early Clinical Data to Predict Clinical Outcome of Tesofensine

✍ Thorsten Lehr; Alexander Staab; Dirk Trommeshauser; Hans Guenter Schaefer; Charl 📂 Article 📅 2010 🏛 American Association of Pharmaceutical Scientists 🌐 English ⚖ 860 KB

Human neural progenitor cells as an in v

Human neural progenitor cells as an in vitro model system to study mitochondrial dysfunction in Alzheimer's disease

✍ Angela M. Cacace; Paul Wes; Marianne Flynn; Cathy Kieras; Sethu Sankaranaryanan; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Development of a human neuronal model sy

Development of a human neuronal model system for the in vitro characterization of pathomechanisms relevant to Alzheimer's disease

✍ Diana Scholz; Marcel Leist 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Should interventions to treat or prevent

Should interventions to treat or prevent Alzheimer’s disease be tested in a population or as targeted treatment of highly selected study participants?

✍ Pierre Jean Ousset,Julien Delrieu,Bruno Vellas 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 138 KB

A multi-center, randomized, double blind

A multi-center, randomized, double blind placebo-controlled trial of estrogens to prevent Alzheimer's disease and loss of memory in women: design and baseline characteristics

✍ Tsai, W.-Y.; Cross, P.; Sano, M.; Jacobs, D.; Andrews, H.; Bell, K.; Graff-Radfo 📂 Article 📅 2008 🏛 SAGE Publications 🌐 English ⚖ 155 KB

P1-144 Validation of a model to assess l

P1-144 Validation of a model to assess long-term disease progression in Alzheimer's disease patients treated with rivastigmine

✍ Brett Hauber; Sean Candrilli; Edward H. Snyder; Christopher R. McBurney 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 163 KB